1. Home
  2. NEPH vs SACH Comparison

NEPH vs SACH Comparison

Compare NEPH & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.99

Market Cap

45.3M

Sector

Health Care

ML Signal

HOLD

Logo Sachem Capital Corp.

SACH

Sachem Capital Corp.

HOLD

Current Price

$1.03

Market Cap

49.6M

Sector

Real Estate

ML Signal

HOLD

Company Overview

Basic Information
Metric
NEPH
SACH
Founded
1997
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
45.3M
49.6M
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
NEPH
SACH
Price
$3.99
$1.03
Analyst Decision
Strong Buy
Hold
Analyst Count
1
3
Target Price
$6.00
$2.00
AVG Volume (30 Days)
50.6K
106.7K
Earning Date
03-23-2026
03-26-2026
Dividend Yield
N/A
19.80%
EPS Growth
N/A
N/A
EPS
0.14
N/A
Revenue
$17,930,000.00
$3,906,000.00
Revenue This Year
$33.32
N/A
Revenue Next Year
$12.27
$1.73
P/E Ratio
$27.87
N/A
Revenue Growth
32.36
N/A
52 Week Low
$1.39
$0.80
52 Week High
$6.42
$1.35

Technical Indicators

Market Signals
Indicator
NEPH
SACH
Relative Strength Index (RSI) N/A N/A
Support Level N/A N/A
Resistance Level N/A N/A
Average True Range (ATR) 0.00 0.00
MACD 0.00 0.00
Stochastic Oscillator 0.00 0.00

Price Performance

Historical Comparison
NEPH
SACH

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

About SACH Sachem Capital Corp.

Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.

Share on Social Networks: